Pacira | PCRX - Trade Debtors


Pacira reported $125.64M in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
Assertio Holdings USD 39.91M 2.7M Jun/2024
Astellas Pharma JPY 761.76B 48.47B Mar/2026
Bristol-Myers Squibb USD 14.36B 164M Mar/2026
Cara Therapeutics USD 2.24M 2.26M Mar/2025
Coherus Biosciences USD 18.42M 232.08M Dec/2025
Heron Therapeutics USD 89.59M 8.54M Dec/2025
Ironwood Pharmaceuticals USD 81.89M 5.68M Dec/2024
J&J USD 21.33B 3.72B Dec/2025
Ligand Pharmaceuticals USD 54.8M 6.25M Mar/2026
Nektar Therapeutics USD 1.78M 1.12M Dec/2025
Novo Nordisk DKK 106.26B 11.21B Mar/2026
Omeros USD 8.08M 440K Jun/2024
Pacira USD 125.64M 1.57M Mar/2026
Perrigo USD 697.1M 84.3M Mar/2026
Pfizer USD 16.17B 332M Mar/2026
Supernus Pharmaceuticals USD 182.18M 5.62M Mar/2026
Teva Pharmaceutical Industries USD 3.39B 316M Mar/2026
Xeris Pharmaceuticals USD 51.05M 2.7M Dec/2025
Xoma USD 14.78M 4.96M Jun/2024
Zoetis USD 1.51B 84M Mar/2026